Extracorporeal membrane oxygenation (ECMO) support has been suggested to improve the survival rate in patients with refractory cardiac arrest (CA). Recent studies have also highlighted the potential early application of this method in improving the prognosis of prolonged cardiac arrest both for in hospital CA (INHCA) and out of hospital CA (OHCA). The rationale for use of ECMO in these patients is to optimize early perfusion of vital organs, curing the cause of CA and waiting for the recovery of the injured myocardium. The investigators have created a flow-chart to decide which patients are eligible. The aims of this study are to evaluate if, with this flow-chart, the investigators are able to detect which patients have more probability of survival.
Study Type
OBSERVATIONAL
Enrollment
40
Insertion of peripheral Veno-Arterious ECMO, subsequent therapeutic hypothermia
San Gerardo Hospital
Monza, MB, Italy
RECRUITING28 days survival
Time frame: 28 days
Neurologic recovery
Neurologic recovery defined as minimal neurologic impairment according to the Glasgow-Pittsburgh cerebral performance categories score ≤ 2.
Time frame: 28 days
Cardiac recovery
Measured by echocardiography
Time frame: 28 days
Six months survival with minimal neurologic impairment
survival with minimal neurologic impairment according to the Glasgow-Pittsburgh cerebral performance categories score ≤ 2.
Time frame: 180 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.